WASHINGTON, Oct 13 (Reuters) - German drugmaker Bayer AG (BAYG.DE: Quote, Profile, Research)(BAY.N: Quote, Profile, Research) said on Friday it had suspended two senior employees over the company’s failure to provide U.S. regulators with data on its heart-surgery drug Trasylol.
